ArticlePharmacoEconomics - open2025
Economic Evaluation of Lecanemab for Early Symptomatic Alzheimer's Disease in South Korea.
Seungyeon Shin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
2025
this papercites it